Bank Of America Corp Dyne Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 176,774 shares of DYN stock, worth $5.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176,774
Previous 152,632
15.82%
Holding current value
$5.27 Million
Previous $4.33 Million
43.96%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DYN
# of Institutions
205Shares Held
105MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$239 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$234 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$220 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$190 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$180 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.54B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...